综述:药物诱导的小肠损伤
药物诱导的胃肠道损伤日益受到关注,小肠和大肠是最常受累部位,占胃肠道副作用的20%-40%。本综述检索PubMed至2021年5月1日,总结与小肠损伤相关的药物,发现非甾体抗炎药、免疫抑制剂、化疗药、抗生素、免疫治疗、依那西普和奥美沙坦关联明确,其他生物制剂、降糖药、降压药、胆碱酯酶抑制剂、钾和铁补充剂可能相关。
要点
- 药物性肠病可从无症状组织学改变到慢性炎症或肠穿孔。
- NSAIDs、免疫抑制剂、化疗药等与小肠损伤关联明确。
- 早期识别并停用致病药物可减少未来并发症风险。
核心结论
- 药物诱导的小肠损伤表现多样,医生应提高认识以早期识别并停用致病药物。
研究设计与样本
- 综述性文献检索,检索PubMed自建库至2021年5月1日,纳入英文原始研究、荟萃分析、系统综述、综述和病例报告。
主要发现
- 药物诱导的肠病可从无症状组织学改变到自限性疾病、模拟炎症性肠病的慢性炎症或肠穿孔。
- 内镜可显示红斑、黏膜脆性增加、水肿、糜烂、溃疡或严重病例的狭窄。
- 组织学可包括黏膜糜烂和溃疡、局灶性活动性肠炎、绒毛萎缩、上皮细胞凋亡或坏死性肠炎。
- 非甾体抗炎药、免疫抑制剂、化疗药、抗生素、免疫治疗、依那西普和奥美沙坦与小肠损伤关联明确。
临床怎么用
- 临床医生应了解药物性肠病的表现,早期识别可及时停用致病药物,降低未来并发症风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Drug-induced gastrointestinal injury has been increasingly reported, but its exact incidence is not known. The small and large intestines represent the most affected sites of injury, accounting for 20%-40% of all gastrointestinal side effects. AIM: To provide an updated literature review detailing medications linked to the development of small bowel injury. METHODS: We conducted a literature search on PubMed from its inception to May 1, 2021. We included English-language original studies, meta-analyses, systematic reviews, review articles and case reports. RESULTS: Drug-induced enteropathy can range from asymptomatic histological changes resulting in a subtle, self-limited disease to a chronic inflammatory condition mimicking inflammatory bowel disease, or bowel perforation. Endoscopy can demonstrate erythema, mucosal friability, oedema, erosions, ulcers or strictures in severe cases. Histology may include mucosal erosions and ulcerations, focal active enteritis, villous atrophy, epithelial apoptosis or necrotising enteritis. A well-established association has been found with the use of nonsteroidal anti-inflammatory drugs, immunosuppressants, chemotherapeutic agents, antibiotics, immunotherapies, etanercept and olmesartan. Possible associations have been reported with other biologic agents, medications used for glycemic control, antihypertensives, cholinesterase inhibitors, potassium and iron supplements, with conflicting data regarding contraceptives/hormonal therapy and isotretinoin. CONCLUSION: Physicians should be aware of the manifestations of drug-induced enteropathy as early recognition can lead to prompt discontinuation of the offending therapy and, therefore, a reduced risk of future complications.
引用
- Hamdeh S, Micic D, Hanauer S, et al. Review article: drug-induced small bowel injury. Aliment Pharmacol Ther. 2021. PMID: 34668591. doi:10.1111/apt.16642
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。